SUV on Dual-Phase FDG PET/CT Correlates With the Ki-67 Proliferation Index in Patients With Newly Diagnosed Non-Hodgkin Lymphoma
Clinical Nuclear Medicine , 07/18/2012
Clinical Article
Chang CC et al. – For patients with newly diagnosed non–Hodgkin lymphoma (NHL), the significant correlation between the Ki–67 index and the SUV in this study suggests that dual–phase FDG PET/CT may be used as a noninvasive measurement of tumor proliferation.



